Financial Statements and Related Announcement::Third Quarter Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
13-Feb-2021 00:27:58
Status
New
Announcement Sub Title
Third Quarter Results
Announcement Reference
SG210213OTHRUAT2
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Unaudited Financial Results (Standalone and Consolidated) for the Third Quarter and Nine Months ended December 31, 2020

Additional Details

For Financial Period Ended
31/03/2020

Attachments

SGX_RESULT_12022021_signed.pdf
Total size =11364K